Actimmune
information and resources from the National Cancer Institute
Actimmune
(Other name for: interferon gamma)
|
|
|
|
news articles
InterMune to Present at the Bear Biotech West Coast Confab Mar 16, 2006
PR Newswire (press release), The pulmonology portfolio includes Actimmune(R) (interferon gamma-1b), which is being evaluated in the INSPIRE Trial, a Phase III study in patients with IPF ...
InterMune Sharpens Focus on Key Development Programs and ... Nov 28, 2005
Yahoo! News (press release) ITMN - News) today announced that it has refocused its corporate strategy to direct resources on three key development programs -- Actimmune® for idiopathic ...
InterMune Sharpens Focus on Key Development Programs and ... Nov 29, 2005
PharmaLive.com (press release), ...today announced that it has refocused its corporate strategy to direct resources on three key development programs -- Actimmune(R) for idiopathic pulmonary ...
InterMune Divesting Infergen For $135.5M, Cuts Work Force Nov 29, 2005
BioWorld Online (subscription), ...year, as the firm reduces money put into awareness programs related to idiopathic pulmonary fibrosis (IPF), for which InterMune has Actimmune (interferon gamma ...
InterMune Elects David S. Kabakoff, Ph.D. To Board Of Directors Dec 1, 2005
PR Newswire (press release), The pulmonology portfolio includes Actimmune(R) (interferon gamma-1b), pirfenidone and research programs. Actimmune(R) is being ...
|
|
